Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: A preliminary investigation on human cell lines and patients

BJU International

Volumn 84, Issue 7, 1999, Pages 845-850

  De La Taille, A ^a   Hayek, O R ^a   Buttyan, R ^a   Bagiella, E ^b   Burchardt, M ^a   Katz, A E ^a,c  

^a Department of Urology ^*  (United States)

^b Columbia Univ Sch of Public Health ^*  (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Hormone therapy; PC SPES; Phytotherapy; Prostate cancer; Prostate specific antigen; PSA

Indexed keywords

ALCOHOL; HEPARIN; HERBACEOUS AGENT; PC SPES; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE; UNCLASSIFIED DRUG;

ADVERSE DRUG REACTION; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD LEVEL; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FOLLOW UP; GYNECOMASTIA; HEPARINIZATION; HORMONAL THERAPY; HOT FLUSH; HUMAN; HUMAN CELL; LEG DISEASE; MALE; NIPPLE; PHYTOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SIDE EFFECT; SKIN SENSITIVITY; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032725428     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1999.00285.x     Document Type: Article

References (13)

1. 1 Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States, Prevalence, costs and patterns of use. N Engl J Med 1993; 328: 246-52
2. 2 Fan S, Wang X. SPES, composition of herbal extracts; USA Patent number 5417979. May 1995
3. 3 DiPaola RS, Zhang H, Lambert GH et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998; 339: 785-91
4. 4 Halicka HD, Ardelt B, Juan G et al. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC-SPES. Int J Oncol 1997; 11: 437-8
5. 5 Hsieh T, Ng C, Chang C, Chen SS, Mittleman A, Wu JM. Induction of apoptosis and down-regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES. Int J Oncol 1998; 13: 1199-202
6. 6 Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55: 4438-45
7. 7 See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of Echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 1997; 35: 229-35
8. 8 Buck AC. Phytotherapy for the prostate. Br J Urol 1996; 78: 325-36
9. 9 Risberg T, Lund E, Wist E, Kaasa S, Wilsgaard T. Cancer patients use of nonproven therapy: a 5-year follow-up study. Clin Oncol 1998; 16: 6-12
10. 10 Risberg T, Wist E, Bremnes RM. Patients' opinion and use of non-proven therapies related to their view on cancer aetiology. Anticancer Res 1998; 18: 499-505
11. 11 Hsieh T, Chen SS, Wang X, Wu JM. Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem Mol Biol Int 1997; 42: 535-44
12. 12 Aprikian AG, Fair WR, Reuter VE et al. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer. Br J Urol 1994; 74: 630-6
13. 13 The Leuprolide Study Group. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984; 311: 1281-6